Skip to main content
Log in

Peptide Acylation by Poly(α-Hydroxy Esters)

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Purpose. Poly(lactic acid) (PLA) and poly(lactic-co-glycolic acid) (PLGA) microspheres were investigated concerning the possible acylation of incorporated peptides.

Methods. Atrial natriuretic peptide (ANP) and salmon calcitonin (sCT) were encapsulated into PLA and PLGA microspheres. Peptide integrity was monitored by HPLC-MS analysis during microsphere degradation for four weeks. sCT fragmentation with endoproteinase Glu-C was used for identifying modified amino acids. Peptide stability in lactic acid solutions was investigated to elucidate possible mechanisms for preventing peptide acylation.

Results. Both peptides were acylated by lactic and glycolic acid units inside degrading microspheres in a time-dependent manner. After 21 days, 60% ANP and 7% sCT inside PLA microspheres were acylated. Fragmentation of sCT with endoproteinase Glu-C revealed that besides the N-terminal amine group, lysine, tyrosine or serine are further possible targets to acylation. Stability studies of the peptides in lactic acid solutions suggest that oligomers are the major acylation source and that lower oligomer concentration and higher pH substantially decreased the reaction velocity.

Conclusions. The use of PLA and PLGA for drug delivery needs substantially more circumspection. As, according to FDA standards, the potential hazards of peptide acylation products need to be assessed, our findings may have significant implications for products already on the market. Techniques to minimize the acylation reaction are suggested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. D. Bailey, E. Zanders, and P. Dean. The end of the beginning for genomic medicine. Nature Biotechnology 19:207–209 (2001).

    Google Scholar 

  2. R. Langer. New methods of drug delivery. Science 249:1527–1533 (1990).

    Google Scholar 

  3. H. Okada. One-and three-month release injectable microspheres of the LH-RH superagonist leuprorelin acetate. Adv. Drug Deliv. Rev. 28:43–70 (1997).

    Google Scholar 

  4. P. J. Camarata, R. Suryanarayanan, D. A. Turner, R. G. Parker, and T. J. Ebner. Sustained release of nerve growth factor from biodegradable polymer microspheres. Neurosurgery 30:313–319 (1992).

    Google Scholar 

  5. S. D. Putney and P. A. Burke. Improving protein therapeutics with sustained-release formulations. Nat. Biotechnol. 16:153–157 (1998).

    Google Scholar 

  6. S. P. Schwendeman, M. Cardamone, M. R. Brandon, A. Klibanov, and R. Langer. Stability of proteins and their delivery from biodegradable polymer microspheres. In S. Cohen and H. Bernstein (eds.), Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996 pp. 1–49.

    Google Scholar 

  7. J. L. Cleland, A. Mac, B. Boyd, J. Yang, E. T. Duenas, D. Yeung, D. Brooks, C. Hsu, H. Chu, V. Mukku, and A. J. Jones. The stability of recombinant human growth hormone in poly(lacticco-glycolic acid) (PLGA) microspheres. Pharm. Res. 14:420–425 (1997).

    Google Scholar 

  8. J. E. Babensee, L. V. McIntire, and A. G. Mikos. Growth factor delivery for tissue engineering. Pharm. Res. 17:497–504 (2000).

    Google Scholar 

  9. K. Y. Lee, M. C. Peters, K. W. Anderson, and D. J. Mooney. Controlled growth factor release from synthetic extracellular matrices. Nature 408:998–1000 (2001).

    Google Scholar 

  10. W. M. Saltzman. Growth factor delivery in Tissue Engineering. MRS Bulletin 21:62–65 (1996).

    Google Scholar 

  11. R. T. Bartus, M. A. Tracy, D. F. Emerich, and S. E. Zale. Sustained delivery of proteins for novel therapeutic drugs. Science 281:1161–1162 (1998).

    Google Scholar 

  12. W. R. Gombotz and D. K. Pettit. Biodegradable polymers for protein and peptide drug delivery. Bioconjug. Chem. 6:332–351 (1995).

    Google Scholar 

  13. S. Cohen and H. Bernstein. Microparticulate Systems for the Delivery of Proteins and Vaccines, Marcel Dekker, New York, 1996.

    Google Scholar 

  14. S. P. Baldwin and W. M. Saltzman. Materials for protein delivery in tissue engineering. Adv. Drug Deliv. Rev. 33:71–86 (1998).

    Google Scholar 

  15. M. van de Weert, W. E. Hennink, and W. Jiskoot. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm. Res. 17:1159–1167 (2000).

    Google Scholar 

  16. A. Brunner, K. Mäder, and A. Göpferich. pH and osmotic pressure inside biodegradable microspheres during erosion. Pharm. Res. 16:847–853 (1999).

    Google Scholar 

  17. G. Zhu, S. R. Mallery, and S. P. Schwendeman. Stabilization of proteins encapsulated in injectable poly(lactide-co-glycolide). Nature Biotechnology 18:52–57 (2000).

    Google Scholar 

  18. A. J. Domb, L. Turovsky, and R. Nudelman. Chemical interactions between drugs containing reactive amines with hydrolyzable insoluble biopolymers in aqueous solutions. Pharm. Res. 11: 865–868 (1994).

    Google Scholar 

  19. S. A. Kidwai, A. A. Ansari, and A. Salahuddin. Effect of succinylation (3-carboxypropionylation) on the conformation and immunological activity of ovalbumin. Biochem. J. 155:171–180 (1976).

    Google Scholar 

  20. M. A. Qasim and A. Salahuddin. Changes in conformation and immunological activity of ovalbumin during its modification with different acid anhydrides. Biochim. Biophys. Acta 536:50–63 (1978).

    Google Scholar 

  21. S. Murase, N. Yumoto, M. G. Petukhov, and S. Yoshikawa. Acylation of the alpha-amino group in neuropeptide Y(12-36) increases binding affinity for the Y2 receptor. J. Biochem. Tokyo 119:37–41 (1996).

    Google Scholar 

  22. S. P. Schwendeman, H. R. Costantino, R. K. Gupta, M. Tobio, A. C. Chang, M. J. Alonso, G. R. Siber, and R. Langer. Strategies for stabilising tetanus toxoid towards the development of a single-dose tetanus vaccine. Dev. Biol. Stand. 87:293–306 (1996).

    Google Scholar 

  23. C. Holten, A. Müller, and D. Rehbinder. Lactic acid: properties and chemistry of lactic acid and derivatives, Verlag Chemie, Weinheim, 1971.

    Google Scholar 

  24. S. Calis, R. Jeyanthi, T. Tsai, R. C. Mehta, and P. P. DeLuca. Adsorption of salmon calcitonin to PLGA microspheres. Pharm. Res. 12:1072–1076 (1995).

    Google Scholar 

  25. A. Göpferich. Polymer bulk erosion. Macromolecules 39:2598–2604 (1997).

    Google Scholar 

  26. F. von Burkersroda, L. Schedl, and A. Göpferich. Why degradable polymers undergo surface erosion or bulk erosion. Biomaterials submitted (2001).

  27. A. Göpferich. Polymer bulk erosion. Macromolecules 39:2598–2604 (1997).

    Google Scholar 

  28. W. Jiang and S. P. Schwendeman. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D,L-lactide) and poly(ethylene glycol) microsphere blends. Pharm. Res. 18:878–885 (2001).

    Google Scholar 

  29. S. J. De Jong, E. R. Arias, D. T. S. Rijkers, C. F. Van Nostrum, J. J. Kettenes-Van den Bosch, and W. E. Hennink. New insights into the hydrolytic degradation of poly(lactic acid): participation of the alcohol terminus. Polymer 42:2795–2802 (2001).

    Google Scholar 

  30. R. P. Haugland. Handbook of fluorescent probes and research chemicals, Molecular Probes Inc., Eugene, Oregon, USA, 1996.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Achim Göpferich.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucke, A., Kiermaier, J. & Göpferich, A. Peptide Acylation by Poly(α-Hydroxy Esters). Pharm Res 19, 175–181 (2002). https://doi.org/10.1023/A:1014272816454

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014272816454

Navigation